Technology
Health
Biotechnology

ResTORbio

$10.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.36 (-3.47%) Today
-$0.01 (-0.10%) As of 4:31 PM EDT after-hours

Why Robinhood?

You can buy or sell ResTORbio and other stocks, options, ETFs, and crypto commission-free!

About TORC

resTORbio, Inc. Common Stock, also called ResTORbio, is a clinical-stage biopharmaceutical company. Read More The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.

Employees
21
Headquarters
Boston, Massachusetts
Founded
2016
Market Cap
352.91M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
170.61K
High Today
$10.78
Low Today
$9.75
Open Price
$10.38
Volume
181.41K
52 Week High
$20.60
52 Week Low
$6.21

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2018 IPO
US

TORC Earnings

-$0.48
-$0.39
-$0.30
-$0.21
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.